(-0.03%) 5 186.22 points
(0.10%) 39 095 points
(-0.25%) 16 262 points
(0.23%) $79.17
(1.78%) $2.23
(0.13%) $2 325.30
(1.46%) $28.01
(0.33%) $987.80
(-0.14%) $0.929
(-0.11%) $10.88
(-0.05%) $0.800
(1.05%) $92.70
0.31% INR 1 450.60
Live Chart Being Loaded With Signals
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally...
Stats | |
---|---|
Today's Volume | 12 950.00 |
Average Volume | 19 823.00 |
Market Cap | 23.99B |
EPS | INR8.01 ( 2024-05-02 ) |
Next earnings date | ( INR0 ) 2024-07-25 |
Last Dividend | INR12.00 ( 2023-07-21 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 27.34 |
ATR14 | INR2.77 (0.19%) |
Volume Correlation
RPG Life Sciences Limited Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
RPG Life Sciences Limited Correlation - Currency/Commodity
RPG Life Sciences Limited Financials
Annual | 2023 |
Revenue: | INR5.82B |
Gross Profit: | INR2.48B (42.66 %) |
EPS: | INR53.01 |
FY | 2023 |
Revenue: | INR5.82B |
Gross Profit: | INR2.48B (42.66 %) |
EPS: | INR53.01 |
FY | 2022 |
Revenue: | INR5.13B |
Gross Profit: | INR3.42B (66.68 %) |
EPS: | INR40.90 |
FY | 2022 |
Revenue: | INR4.37B |
Gross Profit: | INR2.87B (65.64 %) |
EPS: | INR31.13 |
Financial Reports:
No articles found.
RPG Life Sciences Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR9.60 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR12.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR1.200 | 2008-08-11 |
Last Dividend | INR12.00 | 2023-07-21 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 16 | -- |
Total Paid Out | INR51.04 | -- |
Avg. Dividend % Per Year | 1.03% | -- |
Score | 3.1 | -- |
Div. Sustainability Score | 7.98 | |
Div.Growth Potential Score | 5.56 | |
Div. Directional Score | 6.77 | -- |
Year | Amount | Yield |
---|---|---|
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR2.40 | 0.61% |
2019 | INR2.40 | 1.01% |
2020 | INR4.00 | 1.26% |
2021 | INR7.20 | 1.92% |
2022 | INR9.60 | 1.57% |
2023 | INR12.00 | 1.41% |
2024 | INR0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TATVA.NS | Dividend Junior | 2023-09-08 | Annually | 3 | 0.04% | |
NRBBEARING.NS | Dividend Junior | 2023-09-22 | Annually | 23 | 1.22% | |
INDOTHAI.NS | Dividend Junior | 2023-09-15 | Annually | 10 | 0.58% | |
COCHINSHIP.NS | Dividend Knight | 2023-09-21 | Semi-Annually | 7 | 5.03% | |
SBIN.NS | Dividend Junior | 2023-05-31 | Sporadic | 29 | 0.99% | |
MAHLOG.NS | Dividend Junior | 2023-07-13 | Annually | 7 | 0.30% | |
GOACARBON.NS | Dividend Junior | 2023-08-10 | Annually | 18 | 1.38% | |
ATUL.NS | Dividend Junior | 2023-07-13 | Annually | 22 | 0.22% | |
TOUCHWOOD.NS | Dividend Junior | 2023-09-22 | Annually | 6 | 0.15% | |
PGHL.NS | Dividend Junior | 2023-11-13 | Annually | 22 | 0.95% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.151 | 1.500 | 6.99 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.171 | 1.200 | 4.30 | 5.16 | [0 - 0.3] |
returnOnEquityTTM | 0.259 | 1.500 | 8.23 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.28 | 0.800 | 3.62 | 2.90 | [1 - 3] |
quickRatioTTM | 1.342 | 0.800 | 6.81 | 5.45 | [0.8 - 2.5] |
cashRatioTTM | 0.278 | 1.500 | 9.56 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 370.42 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 15.22 | 2.00 | 4.93 | 9.85 | [0 - 30] |
freeCashFlowPerShareTTM | 15.22 | 2.00 | 2.39 | 4.78 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.557 | 1.000 | 4.06 | 4.06 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.197 | 1.000 | 8.05 | 8.05 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 1.135 | 0.800 | 5.77 | 4.61 | [0.5 - 2] |
Total Score | 7.98 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 27.68 | 1.000 | 7.30 | 0 | [1 - 100] |
returnOnEquityTTM | 0.259 | 2.50 | 8.86 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 15.22 | 2.00 | 4.93 | 4.78 | [0 - 30] |
dividendYielPercentageTTM | 0.817 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 15.22 | 2.00 | 4.93 | 9.85 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.965 | 1.500 | 6.90 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0432 | 1.000 | -1.419 | 0 | [0.1 - 0.5] |
Total Score | 5.56 |
RPG Life Sciences Limited
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, anti-spasmodic, etc. It also provides generics primarily in area of immunosuppressant therapy; and finished dosage formulations for various therapies, such as nephrology, rheumatology, oncology, gastroenterology, cardiovascular, diabetology, orthopedics, neuropsychiatry, respiratory, nutritional, general, urology, anti-diabetic, anti-dengue, vitamins and minerals, gynecology and pediatrics, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators